Zaccaria, G.M.; Ferrero, S.; Hoster, E.; Passera, R.; Evangelista, A.; Genuardi, E.; Drandi, D.; Ghislieri, M.; Barbero, D.; Del Giudice, I.;
et al. A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. Cancers 2022, 14, 188.
https://doi.org/10.3390/cancers14010188
AMA Style
Zaccaria GM, Ferrero S, Hoster E, Passera R, Evangelista A, Genuardi E, Drandi D, Ghislieri M, Barbero D, Del Giudice I,
et al. A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. Cancers. 2022; 14(1):188.
https://doi.org/10.3390/cancers14010188
Chicago/Turabian Style
Zaccaria, Gian Maria, Simone Ferrero, Eva Hoster, Roberto Passera, Andrea Evangelista, Elisa Genuardi, Daniela Drandi, Marco Ghislieri, Daniela Barbero, Ilaria Del Giudice,
and et al. 2022. "A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial" Cancers 14, no. 1: 188.
https://doi.org/10.3390/cancers14010188
APA Style
Zaccaria, G. M., Ferrero, S., Hoster, E., Passera, R., Evangelista, A., Genuardi, E., Drandi, D., Ghislieri, M., Barbero, D., Del Giudice, I., Tani, M., Moia, R., Volpetti, S., Cabras, M. G., Di Renzo, N., Merli, F., Vallisa, D., Spina, M., Pascarella, A.,
... Ladetto, M.
(2022). A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. Cancers, 14(1), 188.
https://doi.org/10.3390/cancers14010188
